HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -799.34 Thousand AUD | 77.77% |
| 2022 | -3.59 Million USD | -1755.26% |
| 2021 | -193.81 Thousand AUD | 91.27% |
| 2020 | -2.21 Million AUD | 13.56% |
| 2019 | -2.56 Million AUD | 33.27% |
| 2018 | -3.84 Million AUD | -1270.71% |
| 2017 | 328.58 Thousand AUD | 120.93% |
| 2016 | -1.57 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | -513.92 Thousand AUD | 0.0% |
| 2023 Q2 | -980.11 Thousand USD | 0.0% |
| 2023 FY | -799.34 Thousand AUD | 77.77% |
| 2022 Q4 | -3.59 Million USD | 0.0% |
| 2022 FY | -3.59 Million USD | -1755.26% |
| 2022 Q2 | -2.43 Million USD | 0.0% |
| 2021 Q4 | -193.81 Thousand AUD | 0.0% |
| 2021 Q2 | -2.51 Million USD | 0.0% |
| 2021 FY | -193.81 Thousand AUD | 91.27% |
| 2020 Q2 | -3.03 Million USD | 0.0% |
| 2020 Q4 | -2.21 Million AUD | 0.0% |
| 2020 FY | -2.21 Million AUD | 13.56% |
| 2019 Q4 | -2.56 Million AUD | 0.0% |
| 2019 FY | -2.56 Million AUD | 33.27% |
| 2019 Q2 | -3.39 Million USD | 0.0% |
| 2018 Q2 | -297.24 Thousand USD | 0.0% |
| 2018 FY | -3.84 Million AUD | -1270.71% |
| 2018 Q4 | -5.5 Million USD | 0.0% |
| 2017 Q4 | 330.58 Thousand USD | 0.0% |
| 2017 FY | 328.58 Thousand AUD | 120.93% |
| 2016 FY | -1.57 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 96.864% |
| Adherium Limited | -6.1 Million AUD | 86.905% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 78.668% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 77.816% |
| Anteris Technologies Ltd | -28.49 Million AUD | 97.195% |
| Control Bionics Limited | -19.02 Thousand AUD | -4102.229% |
| CardieX Limited | 2.74 Million AUD | 129.106% |
| Compumedics Limited | 5.08 Million AUD | 115.714% |
| Cochlear Limited | -269.9 Million AUD | 99.704% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 214.423% |
| Cyclopharm Limited | -7.49 Million AUD | 89.341% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 94.909% |
| Nova Eye Medical Limited | -2.8 Million AUD | 71.472% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 105.519% |
| ImpediMed Limited | -23.48 Million AUD | 96.597% |
| InhaleRx Limited | -155.54 Thousand AUD | -413.905% |
| LBT Innovations Limited | -604 Thousand AUD | -32.342% |
| Micro-X Limited | 826.99 Thousand AUD | 196.656% |
| Neurotech International Limited | -2.11 Million AUD | 62.125% |
| OncoSil Medical Limited | -4.43 Million AUD | 81.959% |
| PolyNovo Limited | -30.52 Million AUD | 97.382% |
| Respiri Limited | 413.68 Thousand AUD | 293.224% |
| SomnoMed Limited | -15.16 Million AUD | 94.728% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 84.929% |
| Uscom Limited | -1.53 Million AUD | 47.777% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 80.422% |